Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome following allogeneic hematopoietic cell transplantation though advances in prophylaxis and supportive care have been made. The aim of this study is to test whether the incidence and mortality of aGvHD have decreased...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Greinix, Hildegard T. (VerfasserIn) , Eikema, Dirk-Jan (VerfasserIn) , Koster, Linda (VerfasserIn) , Penack, Olaf (VerfasserIn) , Yakoub-Agha, Ibrahim (VerfasserIn) , Montoto, Silvia (VerfasserIn) , Chabannon, Christian (VerfasserIn) , Styczynski, Jan (VerfasserIn) , Nagler, Arnon (VerfasserIn) , Robin, Marie (VerfasserIn) , Robinson, Stephen (VerfasserIn) , Chalandon, Yves (VerfasserIn) , Mikulska, Malgorzata (VerfasserIn) , Schönland, Stefan (VerfasserIn) , Peric, Zinaida (VerfasserIn) , Ruggeri, Annalisa (VerfasserIn) , Lanza, Francesco (VerfasserIn) , Wreede, Liesbeth C. de (VerfasserIn) , Mohty, Mohamad (VerfasserIn) , Basak, Grzegorz W. (VerfasserIn) , Kröger, Nicolaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: Haematologica
Year: 2022, Jahrgang: 107, Heft: 5, Pages: 1054-1063
ISSN:1592-8721
DOI:10.3324/haematol.2020.265769
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2020.265769
Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/haematol.2020.265769
Volltext
Verfasserangaben:Hildegard T. Greinix, Dirk-Jan Eikema, Linda Koster, Olaf Penack, Ibrahim Yakoub-Agha, Silvia Montoto, Christian Chabannon, Jan Styczynski, Arnon Nagler, Marie Robin, Stephen Robinson, Yves Chalandon, Malgorzata Mikulska, Stefan Schönland, Zinaida Peric, Annalisa Ruggeri, Francesco Lanza, Liesbeth C. de Wreede, Mohamad Mohty, Grzegorz W. Basak and Nicolaus Kröger

MARC

LEADER 00000caa a2200000 c 4500
001 1815967854
003 DE-627
005 20230426132813.0
007 cr uuu---uuuuu
008 220907s2022 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2020.265769  |2 doi 
035 |a (DE-627)1815967854 
035 |a (DE-599)KXP1815967854 
035 |a (OCoLC)1361696565 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Greinix, Hildegard T.  |e VerfasserIn  |4 aut 
245 1 0 |a Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time  |b an EBMT mega-file study  |c Hildegard T. Greinix, Dirk-Jan Eikema, Linda Koster, Olaf Penack, Ibrahim Yakoub-Agha, Silvia Montoto, Christian Chabannon, Jan Styczynski, Arnon Nagler, Marie Robin, Stephen Robinson, Yves Chalandon, Malgorzata Mikulska, Stefan Schönland, Zinaida Peric, Annalisa Ruggeri, Francesco Lanza, Liesbeth C. de Wreede, Mohamad Mohty, Grzegorz W. Basak and Nicolaus Kröger 
264 1 |c 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Pre-published: June 24, 2021 
500 |a Gesehen am 07.09.2022 
520 |a Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome following allogeneic hematopoietic cell transplantation though advances in prophylaxis and supportive care have been made. The aim of this study is to test whether the incidence and mortality of aGvHD have decreased over time. 102,557 patients with a median age of 47.6 years and with malignancies after first allogeneic sibling or unrelated donor (URD) transplant were studied in the following periods: 1990-1995, 1996-2000, 2001-2005, 2006-2010 and 2011-2015. Findings: 100-day incidences of aGvHD grades II-IV decreased from 40% to 38%, 32%, 29% and 28%, respectively, over calendar time (P<0.001). In multivariate analysis URD, not in complete remission (CR) at transplant or untreated, and female donor for male recipient were factors associated with increased risk whereas the use of ATG/alemtuzumab decreased aGvHD incidence. Median follow-up was 214, 169, 127, 81 and 30 months, respectively, for the periods analyzed. Three-year-survival after aGvHD grades II-IV increased significantly from 38% to 40%, 43%, 44%, and 45%, respectively. In multivariate analysis URD, not in CR at transplant, peripheral blood as stem cell source, female donor for male recipient, and the use of ATG/alemtuzumab were associated with increased mortality whereas reduced-intensity conditioning was linked to lower mortality. Mortality increased with increasing patient age but decreased in the recent cohorts. Our analysis demonstrates that aGvHD has decreased over recent decades and also that the survival rates of patients affected with aGvHD has improved. 
700 1 |a Eikema, Dirk-Jan  |e VerfasserIn  |4 aut 
700 1 |a Koster, Linda  |e VerfasserIn  |4 aut 
700 1 |a Penack, Olaf  |e VerfasserIn  |4 aut 
700 1 |a Yakoub-Agha, Ibrahim  |e VerfasserIn  |4 aut 
700 1 |a Montoto, Silvia  |e VerfasserIn  |4 aut 
700 1 |a Chabannon, Christian  |e VerfasserIn  |4 aut 
700 1 |a Styczynski, Jan  |e VerfasserIn  |4 aut 
700 1 |a Nagler, Arnon  |e VerfasserIn  |4 aut 
700 1 |a Robin, Marie  |e VerfasserIn  |4 aut 
700 1 |a Robinson, Stephen  |e VerfasserIn  |4 aut 
700 1 |a Chalandon, Yves  |e VerfasserIn  |4 aut 
700 1 |a Mikulska, Malgorzata  |e VerfasserIn  |4 aut 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
700 1 |a Peric, Zinaida  |e VerfasserIn  |4 aut 
700 1 |a Ruggeri, Annalisa  |e VerfasserIn  |4 aut 
700 1 |a Lanza, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Wreede, Liesbeth C. de  |e VerfasserIn  |4 aut 
700 1 |a Mohty, Mohamad  |e VerfasserIn  |4 aut 
700 1 |a Basak, Grzegorz W.  |e VerfasserIn  |4 aut 
700 1 |a Kröger, Nicolaus  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 107(2022), 5, Seite 1054-1063  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time an EBMT mega-file study 
773 1 8 |g volume:107  |g year:2022  |g number:5  |g pages:1054-1063  |g extent:10  |a Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time an EBMT mega-file study 
856 4 0 |u https://doi.org/10.3324/haematol.2020.265769  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/haematol.2020.265769  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220907 
993 |a Article 
994 |a 2022 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |d 50000  |e 910000PS122405226  |e 910100PS122405226  |e 50000PS122405226  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 14 
999 |a KXP-PPN1815967854  |e 4185292740 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1815967854"],"doi":["10.3324/haematol.2020.265769"]},"name":{"displayForm":["Hildegard T. Greinix, Dirk-Jan Eikema, Linda Koster, Olaf Penack, Ibrahim Yakoub-Agha, Silvia Montoto, Christian Chabannon, Jan Styczynski, Arnon Nagler, Marie Robin, Stephen Robinson, Yves Chalandon, Malgorzata Mikulska, Stefan Schönland, Zinaida Peric, Annalisa Ruggeri, Francesco Lanza, Liesbeth C. de Wreede, Mohamad Mohty, Grzegorz W. Basak and Nicolaus Kröger"]},"physDesc":[{"extent":"10 S."}],"recId":"1815967854","relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time an EBMT mega-file studyHaematologica","title":[{"title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica"}],"origin":[{"publisherPlace":"Pavia","dateIssuedDisp":"2014-","publisher":"Ferrata Storti Foundation","dateIssuedKey":"2014"}],"note":["Gesehen am 27.05.2022"],"pubHistory":["99.2014 -"],"id":{"eki":["814204899"],"zdb":["2805244-4"],"issn":["1592-8721"]},"recId":"814204899","physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"10","volume":"107","text":"107(2022), 5, Seite 1054-1063","issue":"5","year":"2022","pages":"1054-1063"},"titleAlt":[{"title":"journal of the European Hematology Association"}],"language":["eng"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Pre-published: June 24, 2021","Gesehen am 07.09.2022"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"title":[{"subtitle":"an EBMT mega-file study","title_sort":"Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time","title":"Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time"}],"language":["eng"],"person":[{"given":"Hildegard T.","role":"aut","family":"Greinix","display":"Greinix, Hildegard T."},{"family":"Eikema","display":"Eikema, Dirk-Jan","role":"aut","given":"Dirk-Jan"},{"display":"Koster, Linda","family":"Koster","role":"aut","given":"Linda"},{"family":"Penack","display":"Penack, Olaf","given":"Olaf","role":"aut"},{"given":"Ibrahim","role":"aut","family":"Yakoub-Agha","display":"Yakoub-Agha, Ibrahim"},{"given":"Silvia","role":"aut","family":"Montoto","display":"Montoto, Silvia"},{"display":"Chabannon, Christian","family":"Chabannon","given":"Christian","role":"aut"},{"family":"Styczynski","display":"Styczynski, Jan","role":"aut","given":"Jan"},{"display":"Nagler, Arnon","family":"Nagler","role":"aut","given":"Arnon"},{"display":"Robin, Marie","family":"Robin","given":"Marie","role":"aut"},{"given":"Stephen","role":"aut","display":"Robinson, Stephen","family":"Robinson"},{"role":"aut","given":"Yves","display":"Chalandon, Yves","family":"Chalandon"},{"given":"Malgorzata","role":"aut","display":"Mikulska, Malgorzata","family":"Mikulska"},{"display":"Schönland, Stefan","family":"Schönland","given":"Stefan","role":"aut"},{"display":"Peric, Zinaida","family":"Peric","given":"Zinaida","role":"aut"},{"display":"Ruggeri, Annalisa","family":"Ruggeri","role":"aut","given":"Annalisa"},{"role":"aut","given":"Francesco","display":"Lanza, Francesco","family":"Lanza"},{"family":"Wreede","display":"Wreede, Liesbeth C. de","given":"Liesbeth C. de","role":"aut"},{"family":"Mohty","display":"Mohty, Mohamad","role":"aut","given":"Mohamad"},{"family":"Basak","display":"Basak, Grzegorz W.","given":"Grzegorz W.","role":"aut"},{"display":"Kröger, Nicolaus","family":"Kröger","role":"aut","given":"Nicolaus"}]} 
SRT |a GREINIXHILIMPROVEDOU2022